AP NEWS

2-Day Conference: Inhaled Drug Delivery (London, United Kingdom - November 1-2, 2018) - ResearchAndMarkets.com

September 17, 2018

DUBLIN--(BUSINESS WIRE)--Sep 17, 2018--The “Inhaled Drug Delivery” conference has been added to ResearchAndMarkets.com’s offering.

Inhaled drug delivery is achieved using four principle technologies, dry powder inhalers, metered dose inhalers, nebulizers and liquid inhalers. Although there are many differences between these technologies there are many fundamental principles that are followed to achieve an effective delivered dose, as such there is much shared learning across the technologies.

This meeting includes presentations on each of these delivery technologies with the intent to share knowledge and learning across the inhaled drug development business. The future European and UK regulatory processes following Brexit will be critical when developing product approval strategies, we shall be considering regulatory issues on this and other important hot topics.

There are a number of key areas that are currently evolving and the latest thinking and progress on these will be presented, including Human factor design and sensing/connecting technologies. These key evolving areas are subject to much debate and require careful consideration whilst developing an inhaled drug product.

Programme to include:

Modern respiratory medicines Innovation in nebulized therapy Current and future trends for DPI formulation Opportunities of nanoformulations in the lung The role of lung protease in delivery of inhaled biopharmaceuticals Lung deposition software: Mimetikos preludium: a new pharma friendly aerosol drug deposition calculator Could smart inhalers dramatically change the way that Asthma and COPD patients are treated? Decoding FDA’s recent combination drug product guidance: Applications to DPIs, pMDIs, and nasal sprays The UK regulatory future - the way forward after Brexit Navigating human factors in device development The 1nhaler and its two jobs Opportunities and challenges in the design of high-performance unit-dose dry powder inhalers Design characterization of breath actuation mechanisms Digitally enabled inhalers

For more information about this conference visit https://www.researchandmarkets.com/research/fvbmkg/2day_conference?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180917005289/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Inhalers and Nebulisers

KEYWORD: UNITED KINGDOM EUROPE

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PHARMACEUTICAL COMMUNICATIONS OTHER COMMUNICATIONS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/17/2018 06:35 AM/DISC: 09/17/2018 06:35 AM

http://www.businesswire.com/news/home/20180917005289/en

AP RADIO
Update hourly